Every claim we hold, and how far we can stand behind it.
142 claims across 39 products. 30% are confirmed against the source text by the evidence gate; 39% come from a class with no vendor interest. Everything below is browsable, filterable, and available as JSON.
| Evidence class | Claims | Confirmed | What it can support |
|---|---|---|---|
| Peer-reviewed study | 19 | 5 | Independent review before publication. The only class that survives a sceptical committee unaided. |
| Regulatory filing | 4 | 0 | A statement made to a regulator, where being wrong has consequences. |
| Independent report | 32 | 9 | Analysis by someone with no stake in the sale. |
| Customer case | 4 | 3 | A real deployment, but selected and framed by someone with an interest. |
| Press release | 63 | 23 | The vendor's own announcement. Useful for dates and facts, not for outcomes. |
| Vendor page | 20 | 2 | Marketing copy. Establishes what is claimed, never that it is true. |
Showing 4 of 4 matching claims (142 in the full corpus) · 0% of this selection is confirmed · clear filters
In the physician-validated Harvard-Stanford ARISE NOHARM clinical safety benchmark, Glass ranked among the top medical AI systems, ahead of models from OpenAI and Anthropic; Glass reasons over 38M+ peer-reviewed citations, current clinical guidelines, and 150,000+ FDA drug labels with cited answers
Provenance
- Claim ID
- clm_c3a9fcb6efd65b5dbe47
- Version
- 1
- Workflow
- Clinical Evidence & Decision Support
- Dimension
- evidence strength
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://glass.health/features
Infermedica's Medical Guidance Platform (Triage, Intake, Follow-up modules) achieved EU MDR Class IIb certification, one of the highest compliance levels for Software as a Medical Device in Europe; Conversational Triage, its agentic neurosymbolic AI product launched April 2025, is in the process of MDR certification expected 2026
Provenance
- Claim ID
- clm_62f80b6c194758cc9caf
- Version
- 1
- Workflow
- Clinical Evidence & Decision Support
- Dimension
- trust governance
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://infermedica.com/blog/articles/infermedica-2025-a-year-in-review
Infermedica's solutions crossed 25 million completed health checkups and, with Healthdirect Australia, generated a 71% increase in self-assessment completion rates, a 9% improvement in triage accuracy, and a 46% reduction in overtriage versus the legacy system, serving 26 million Australians
Provenance
- Claim ID
- clm_9c06762efec404b82938
- Version
- 1
- Workflow
- Clinical Evidence & Decision Support
- Dimension
- deployment traction
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://infermedica.com/blog/articles/infermedica-2025-a-year-in-review
The July 2025 announcement introduced the wide release of DeepConsult, with the feature free to verified U.S. clinicians, expanding Glass AI's clinical reasoning capabilities
Provenance
- Claim ID
- clm_9d055fa3533df063eee3
- Version
- 1
- Workflow
- Clinical Evidence & Decision Support
- Dimension
- deployment traction
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://glass.health/compare/openevidence